NCT04575623

Brief Summary

Migraine is a neurological disease associated with an altered cortical excitability level . The prevalence of migraine is10.5% of adults in Assiut governorate, and is more frequent in women and in individuals with higher education level . There is evidence that migraine patients could present cognitive deficits, being the affected functions memory, processing information speed and attention. It was found that the prevalence of migraine in AlQuseir was 4.8/100 and the highest figures found during early adult life(18-40) years old .Patients with migraine found to perform significantly worse in duration pattern test(DPT),non-verbal dichotic test ,speech in noise (SPIN)test and found to have longer p300 frequency stimulus latency which indicate presence of cognitive and central auditory processing dysfunction

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2021

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 5, 2020

Completed
12 months until next milestone

Study Start

First participant enrolled

October 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2023

Completed
Last Updated

February 1, 2021

Status Verified

January 1, 2021

Enrollment Period

1 year

First QC Date

September 28, 2020

Last Update Submit

January 28, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Determination of central auditory processing in patients with migraine

    Evaluation of auditory functions in patients with migraine by using Duration Pattern test (DPT) designed to test temporal ordering abilities. Dichotic Digits Test (DDT) it assesses binaural integration skills. Auditory fusion test-revised (ART-R) to measure temporal resolution. speech in test to assess central auditory function.

    One year

  • Determination of cognitive functions in patients with migraine

    Evaluation of cognitive functions in patients with migraine by Recording of event-related potentials (ERPs) by using odd ball paradigm auditoryP300 wave in evaluating cerebral information processing

    One year

Study Arms (1)

Study group

It will consist of 120 patients suffering from migraine according to international classification of headache

Diagnostic Test: Duration Pattern test (DPT) /Dichotic Digits Test (DDT) /Auditory fusion test-revised (ART-R)/Device: Dual band pure tone audiometer (Orbiter 992). -Impedance audiometer (AT 235h). -Sound treated booth (industrial acoustic company IAC model 1602-A-t) -Panasonic stereo CD player SA-AK 240.

Interventions

Central auditory function evaluation including: * Duration Pattern test (DPT) designed to test temporal ordering abilities. * Dichotic Digits Test (DDT) it assesses binaural integration skills. * Auditory fusion test-revised (ART-R) to measure temporal resolution. * speech in test to assess central auditory function.

Study group

Cognitive function evaluation including: -Recording of event-related potentials (ERPs) by using odd ball paradigm auditoryP300 wave in evaluating cerebral information processing. Equipment: * Dual band pure tone audiometer (Orbiter 992). * Impedance audiometer (AT 235h). * Sound treated booth (industrial acoustic company IAC model 1602-A-t) * Panasonic stereo CD player SA-AK 240.

Study group

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients with migraine as study group and normal people as control group

You may qualify if:

  • It will consist of 100 patients suffering from migraine according to international classification of headache.
  • Their age range from (18-40) years old which considered the most common affected age group ,
  • Both sexes will be included.
  • The study group will be further classified into two main categories migraine with and without aura.

You may not qualify if:

  • Patients with history of systemic, neurologic or psychiatric illness.
  • Patients with other types of headache.
  • Patients with hearing loss.
  • Patients with history of head trauma, surgery or ototoxic drug therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Migraine Disorders

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

September 28, 2020

First Posted

October 5, 2020

Study Start

October 1, 2021

Primary Completion

October 1, 2022

Study Completion

October 1, 2023

Last Updated

February 1, 2021

Record last verified: 2021-01